
Join to View Full Profile
315 E BroadwayLouisville, KY 40202
Phone+1 502-629-2500
Fax+1 502-629-3166
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Hamm, MD is an oncologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Indiana.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1987
University of Louisville School of MedicineResidency, Internal Medicine, 1982 - 1985
Vanderbilt University School of MedicineClass of 1982
Certifications & Licensure
IN State Medical License 1987 - 2027
KY State Medical License 1983 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.Jared Weiss, Douglas Laux, David Bajor, Albert C Lockhart, John Hamm
Future Science OA. 2024-12-01 - 10 citationsComparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomize...Caicun Zhou, Minu K Srivastava, Hao Xu, Enriqueta Felip, Heather Wakelee
Journal for Immunotherapy of Cancer. 2023-10-01 - 103 citationsNRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.Christina I Tsien, Stephanie L Pugh, Adam P Dicker, Jeffrey J Raizer, Martha M Matuszak
Journal of Clinical Oncology. 2023-02-20
Press Mentions
Immunotherapy Revived Coach Mike Cassity During Battle with MyelomaJune 23rd, 2025
Norton Cancer Institute: Advancing Cancer Care Through Clinical ResearchJune 4th, 2025









